In a phase 1 open‐label clinical trial, glucose homeostasis in patients with T2D was observed to be regulated not only by GK activation in the pancreas and liver but also through the improvement of GLP‐1 release.26 This evidence concerns the gene GK and type 2 diabetes mellitus.